News

The Active Pharmaceutical Ingredient (API) business of Arevipharma at their Radebeul site will be extended by innovation and investments, with strategic focus on outstanding quality, customer service as well as secured supplies and supply chains Radebeul, Germany – by 1st of January 2021 the acquisition of Arevipharma by Yonsung Group…

Dear Stakeholders, This is to inform you that our site in Radebeul, Germany, was inspected by the US Food and Drug Administration (US-FDA) from 25. – 29. April 2016. The audit has covered quality systems, equipment and facilities, materials, production, packaging, labeling and laboratory controls. We are proud to announce…